Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2)

BACKGROUND: Worldwide data for cancer survival are scarce. We aimed to initiate worldwide surveillance of cancer survival by central analysis of population-based registry data, as a metric of the effectiveness of health systems, and to inform global policy on cancer control. METHODS: Individual tumour records were submitted by 279 population-based cancer registries in 67 countries for 25·7 million adults (age 15-99 years) and 75,000 children (age 0-14 years) diagnosed with cancer during 1995-2009 and followed up to Dec 31, 2009, or later. We looked at cancers of the stomach, colon, rectum, liver, lung, breast (women), cervix, ovary, and prostate in adults, and adult and childhood leukaemia. Standardised quality control procedures were applied; errors were corrected by the registry concerned. We estimated 5-year net survival, adjusted for background mortality in every country or region by age (single year), sex, and calendar year, and by race or ethnic origin in some countries. Estimates were age-standardised with the International Cancer Survival Standard weights. FINDINGS: 5-year survival from colon, rectal, and breast cancers has increased steadily in most developed countries. For patients diagnosed during 2005-09, survival for colon and rectal cancer reached 60% or more in 22 countries around the world; for breast cancer, 5-year survival rose to 85% or higher in 17 countries worldwide. Liver and lung cancer remain lethal in all nations: for both cancers, 5-year survival is below 20% everywhere in Europe, in the range 15-19% in North America, and as low as 7-9% in Mongolia and Thailand. Striking rises in 5-year survival from prostate cancer have occurred in many countries: survival rose by 10-20% between 1995-99 and 2005-09 in 22 countries in South America, Asia, and Europe, but survival still varies widely around the world, from less than 60% in Bulgaria and Thailand to 95% or more in Brazil, Puerto Rico, and the USA. For cervical cancer, national estimates of 5-year survival range from less than 50% to more than 70%; regional variations are much wider, and improvements between 1995-99 and 2005-09 have generally been slight. For women diagnosed with ovarian cancer in 2005-09, 5-year survival was 40% or higher only in Ecuador, the USA, and 17 countries in Asia and Europe. 5-year survival for stomach cancer in 2005-09 was high (54-58%) in Japan and South Korea, compared with less than 40% in other countries. By contrast, 5-year survival from adult leukaemia in Japan and South Korea (18-23%) is lower than in most other countries. 5-year survival from childhood acute lymphoblastic leukaemia is less than 60% in several countries, but as high as 90% in Canada and four European countries, which suggests major deficiencies in the management of a largely curable disease. INTERPRETATION: International comparison of survival trends reveals very wide differences that are likely to be attributable to differences in access to early diagnosis and optimum treatment. Continuous worldwide surveillance of cancer survival should become an indispensable source of information for cancer patients and researchers and a stimulus for politicians to improve health policy and health-care systems

Reação de cultivares de batata a Streptomyces scabies, agente causal da sarna comum profunda Reaction of potato cultivars to Streptomyces scabies, causal agent of deep common scab

Este trabalho visou caracterizar quanto a critérios morfológicos e fisiológicos isolados de Streptomyces causadores de sarna comum profunda em batata; avaliar o comportamento de cultivares em relação à doença e a variação na agressividade entre os isolados da bactéria. Os isolados de Streptomyces apresentaram coloração cinza em meio extrato de levedura e malte e cadeias de esporos espiraladas, produzidas sobre um micélio aéreo. Ocorreu produção de melanina em meio de tirosina-ágar e a utilização de oito fontes de carbono recomendadas, propriedades estas que correspondem às descritas para S. scabies. Batatas-semente sadias de seis cultivares foram plantadas em substrato infestado com seis isolados de S. scabies separadamente e as plantas cultivadas em vasos e ambiente aberto. A severidade da doença foi estimada com auxílio de uma escala diagramática e avaliou-se o rendimento de tubérculos (g/planta). As cvs. Mondial e Jaete Bintje foram as mais resistentes à sarna comum com severidade média nos dois experimentos de 10,5% e 14,0%, respectivamente, seguidas por Asterix (17,4%), Ágata (21,8%), Monalisa (23,0%) e Cupido (23,3%). A agressividade dos isolados variou quantitativamente, com severidade maior para o isolado M4 (34,7%) e menor para o isolado M1 (6,2%). Redução da produção de tubérculos foi verificada na cv. Jaete Bintje, no primeiro experimento, e quando as cultivares foram infectadas pelos isolados A1, M2 e M3, no primeiro experimento, e pelo isolado M4, no segundo experimento.<br>This work aimed to characterize the isolates of Streptomyces, responsible for deep common scab symptoms in potato, according to morphological and physiological criteria; to evaluate the resistance of potato cultivars to the disease and the aggressiveness of bacterium isolates. The Streptomyces isolates presented gray coloration on yeast extract and malt medium and spiral spore chains, produced on aerial hyphae. Production of melanina occurred in tirosine-agar medium and the utilization of eight recommended carbon sources. These properties correspond to the S. scabies species. Healthy potato seeds of six cultivars were planted in substratum infested with six isolates of S. scabies separately, and the plants cultivated in plastic bags and under open sky. The scab severity was evaluated with a diagrammatic scale and evaluated the tuber production (g/plant). Cvs. Mondial and Jaete Bintje were the most resistant to the common scab with average severity of 10.5% and 14.0%, respectively, followed by cv. Asterix (17.4%), Agata (21.8%), Monalisa (23.0%) and Cupido (23.3%). The aggressiveness of the isolates varied quantitatively, with higher severity for the isolate M4 (34.7%) and minor for the isolate M1 (6.2%). Reduction of tuber production was verified in cv. Jaete Bintje in the first experiment, and when the cultivars were infected by isolates A1, M2 and M3 in the first experiment and by isolate M4 in the second experiment

Recessive Missense Mutations in Lamb2 Expand the Clinical Spectrum of Lamb2-Associated Disorders

Congenital nephrotic syndrome is clinically and genetically heterogeneous. The majority of cases can be attributed to mutations in the genes NPHS1, NPHS2, and WT1. By homozygosity mapping in a consanguineous family with isolated congenital nephrotic syndrome, we identified a potential candidate region on chromosome 3p. The LAMB2 gene, which was recently reported as mutated in Pierson syndrome (microcoria-congenital nephrosis syndrome; OMIM #609049), was located in the linkage interval. Sequencing of all coding exons of LAMB2 revealed a novel homozygous missense mutation (R246Q) in both affected children. A different mutation at this codon (R246W), which is highly conserved through evolution, has recently been reported as causing Pierson syndrome. Subsequent LAMB2 mutational screening in six additional families with congenital nephrotic syndrome revealed compound heterozygosity for two novel missense mutations in one family with additional nonspecific ocular anomalies. These findings demonstrate that the spectrum of LAMB2-associated disorders is broader than previously anticipated and includes congenital nephrotic syndrome without eye anomalies or with minor ocular changes different from those observed in Pierson syndrome. This phenotypic variability likely reflects specific genotypes. We conclude that mutational analysis in LAMB2 should be considered in congenital nephrotic syndrome, if no mutations are found in NPHS1, NPHS2, or WT1.WoSScopu